Coronavirus Notebook: 35 Generic Firms To Produce Pfizer’s Paxlovid, AZ’s Evusheld Gains UK & Australian Approval

 
• By Ian Schofield

Finland’s Rokote expects to begin clinical trials with its intranasal vaccine after the summer, while Australia’s ENA Respiratory has dosed the first patients in a Phase IIa study of its antiviral nasal spray.

Coronavirus Disease 2019 or Covid-19 information map showing infection risk area - Concept of medical big data science analytic
Companies across the world will be able to produce Pfizer's COVID-19 therapy • Source: Alamy

More from International

More from Geography